{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T13:19:15Z","timestamp":1783171155382,"version":"3.54.6"},"reference-count":24,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity"],"published-print":{"date-parts":[[2000,1]]},"DOI":"10.3109\/08916930008994083","type":"journal-article","created":{"date-parts":[[2009,12,7]],"date-time":"2009-12-07T18:25:04Z","timestamp":1260210304000},"page":"133-144","source":"Crossref","is-referenced-by-count":40,"title":["Peripheral Neuropathy Associated with Anti-GM2 Ganglioside Antibodies: Clinical and Immunopathological Studies"],"prefix":"10.1080","volume":"32","author":[{"given":"Graham m.","family":"Ohanlon","sequence":"first","affiliation":[{"name":"University of Glasgow Department of Neurology, Southern General Hospital, Glasgow, G51 4TF, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Veitch","sequence":"additional","affiliation":[{"name":"University of Glasgow Department of Neurology, Southern General Hospital, Glasgow, G51 4TF, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Gallardo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hospital Universitari Sta. Creu i Sant Pau, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Illa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hospital Universitari Sta. Creu i Sant Pau, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Chancellor","sequence":"additional","affiliation":[{"name":"Department of Neurology, Western Bay Health, Tauranga, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh J.","family":"Willison","sequence":"additional","affiliation":[{"name":"University of Glasgow Department of Neurology, Southern General Hospital, Glasgow, G51 4TF, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2009,7,7]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)12308-X"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(99)00213-1"},{"key":"e_1_2_1_4_1","first-page":"3","article-title":"Anti-ganglioside antibody and neuropathy: Review of our research. J","volume":"3","author":"Yuki N","year":"1998","unstructured":"Yuki N. Anti-ganglioside antibody and neuropathy: Review of our research. J. Periph. Nerv. Sys. 1998; 3: 3\u201318","journal-title":"Periph. Nerv. Sys."},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)68935-5"},{"key":"e_1_2_1_6_1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1471-4159.1988.tb01821.x","article-title":"Identification and characterization of gangliosides reacting with IgM paraproteins in three patients with neuropathy associated with biclonal gammopathy","volume":"51","author":"Ilyas A A","year":"1988","unstructured":"Ilyas A A, Willison H J, Dalakas M C, Whitaker J N, Quarles R H. Identification and characterization of gangliosides reacting with IgM paraproteins in three patients with neuropathy associated with biclonal gammopathy. J. Neurochem 1988; 51: 851\u20138","journal-title":"J. Neurochem"},{"key":"e_1_2_1_7_1","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/0140-6736(91)91767-O","article-title":"Motoneuron-disease-like disorder after ganglioside therapy","volume":"337","author":"Yuki N","year":"1991","unstructured":"Yuki N, Sato S, Miyatake T, Sugiyama K, Katagiri T, Sasaki H. Motoneuron-disease-like disorder after ganglioside therapy. Lancet 1991; 337: 1109\u201310","journal-title":"Lancet"},{"key":"e_1_2_1_8_1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0165-5728(98)00245-8","article-title":"Anti-GM2 IgM antibodies: Clinical correlates and reactivity with a human neuroblastoma cell line","volume":"94","author":"Cavanna B","year":"1999","unstructured":"Cavanna B, Carpo M, Pedotti R, Scarpini E, Meucci N, Allaria S, et al. Anti-GM2 IgM antibodies: Clinical correlates and reactivity with a human neuroblastoma cell line. J. Neuroimmunol 1999; 94: 157\u201364","journal-title":"J. Neuroimmunol"},{"key":"e_1_2_1_9_1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0165-5728(94)00129-C","article-title":"Presence and isotype of anti-ganglioside antibodies in healthy persons, motor neuron disease, peripheral neuropathy, and other diseases of the nervous system","volume":"56","author":"Guijo C G","year":"1995","unstructured":"Guijo C G, Garcia-Merino A, Rubio G. Presence and isotype of anti-ganglioside antibodies in healthy persons, motor neuron disease, peripheral neuropathy, and other diseases of the nervous system. J. Neuroimmunol 1995; 56: 27\u201333","journal-title":"J. Neuroimmunol"},{"key":"e_1_2_1_10_1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0165-5728(94)90048-5","article-title":"Characterization of anti-ganglioside antibodies present in normal human plasma","volume":"50","author":"Mizutamari R K","year":"1994","unstructured":"Mizutamari R K, Wiegandt H, Nores G A. Characterization of anti-ganglioside antibodies present in normal human plasma. J. Neuroimmunol 1994; 50: 215\u201320","journal-title":"J. Neuroimmunol"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410360313"},{"key":"e_1_2_1_12_1","first-page":"106","article-title":"Guillain-Barre syndrome with high titers of anti-GM2 and anti-GalNAc-GDla antibody following cytomegalovirus hepatitis","volume":"37","author":"Shimoya K","year":"1997","unstructured":"Shimoya K, Ohnishi A, Hashimoto T, Yuki N. Guillain-Barre syndrome with high titers of anti-GM2 and anti-GalNAc-GDla antibody following cytomegalovirus hepatitis. Clin. Neurol 1997; 37: 106\u201310","journal-title":"Clin. Neurol"},{"key":"e_1_2_1_13_1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/BF00856811","article-title":"Ganglioside antibodies: A lack of diagnostic specificity and clinical utility?","volume":"239","author":"Weller M","year":"1992","unstructured":"Weller M, Stevens A, Sommer N, Dichgans J, Kappler B, Wietholter H. Ganglioside antibodies: A lack of diagnostic specificity and clinical utility?. J. Neurol 1992; 239: 455\u20139","journal-title":"J. Neurol"},{"key":"e_1_2_1_14_1","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1002\/ana.410270710","article-title":"Antibody detection in Guillain-Barre syndrome","volume":"27","author":"Svennerholm L","year":"1990","unstructured":"Svennerholm L, Fredman P. Antibody detection in Guillain-Barre syndrome. Ann. Neurol 1990; 27: S36\u2013S40","journal-title":"Ann. Neurol"},{"key":"e_1_2_1_15_1","first-page":"1371","article-title":"IgM anti-(GalNAc 4-1-4 Gal[3-2-a-NeuAc]P-l-) Antibody-mediated cytotoxicity in a patient with amyotrophic-lateral-sclerosis - like disorder","volume":"15","author":"Yuki N","year":"1992","unstructured":"Yuki N, Miyatake T, Ichihashi Y, Sato S, Katagiri T. IgM anti-(GalNAc 4-1-4 Gal[3-2-a-NeuAc]P-l-) Antibody-mediated cytotoxicity in a patient with amyotrophic-lateral-sclerosis - like disorder. Muscle Nerve 1992; 15: 1371\u20133","journal-title":"Muscle Nerve"},{"key":"e_1_2_1_16_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0022-510X(93)90300-N","article-title":"Antiglycolipid antibodies, immunoglobulins and paraproteins in motor- neuron disease - a population based case-control study","volume":"114","author":"Willison H J","year":"1993","unstructured":"Willison H J, Chancellor A M, Paterson G, Veitch J, Singh S, Whitelaw J, et al. Antiglycolipid antibodies, immunoglobulins and paraproteins in motor- neuron disease - a population based case-control study. J. Neurol. Sci. 1993; 114: 209\u201315","journal-title":"J. Neurol. Sci."},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.1999.610071.x"},{"key":"e_1_2_1_18_1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ana.410350416","article-title":"Cloning of human anti-GM 1 antibodies from motor neuropathy patients","volume":"35","author":"Willison H J","year":"1994","unstructured":"Willison H J, Paterson G, Kennedy P GE, Veitch J. Cloning of human anti-GM 1 antibodies from motor neuropathy patients. Ann. Neurol 1994; 35: 471\u20138","journal-title":"Ann. Neurol"},{"key":"e_1_2_1_19_1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0022-510X(95)00101-7","article-title":"Ganglioside characterization of a cell-line displaying motor neuron- like phenotype - GM2 as a possible major ganglioside in motor-neurons","volume":"131","author":"Matsumoto A","year":"1995","unstructured":"Matsumoto A, Yoshino H, Yuki N, Hara Y, Cashman N R, Handa S, et al. Ganglioside characterization of a cell-line displaying motor neuron- like phenotype - GM2 as a possible major ganglioside in motor-neurons. J. Neurol. Sci. 1995; 131: 111\u20138","journal-title":"J. Neurol. Sci."},{"key":"e_1_2_1_20_1","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/00005072-199602000-00007","article-title":"Anti-GMl ganglioside antibodies cloned from autoimmune neuropathy patients show diverse binding patterns in the rodent nervous system","volume":"55","author":"O'Hanlon G M","year":"1996","unstructured":"O'Hanlon G M, Paterson G J, Wilson G, Doyle D, McHardie P, Willison H J. Anti-GMl ganglioside antibodies cloned from autoimmune neuropathy patients show diverse binding patterns in the rodent nervous system. J. Neuropath. Exp. Neurol 1996; 55: 184\u201395","journal-title":"J. Neuropath. Exp. Neurol"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410310619"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199902)45:2<189::AID-ANA9>3.0.CO;2-T"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410390404"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/122.5.807"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(96)00059-8"}],"container-title":["Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/08916930008994083","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T08:15:51Z","timestamp":1720685751000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/08916930008994083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,1]]}},"alternative-id":["10.3109\/08916930008994083"],"URL":"https:\/\/doi.org\/10.3109\/08916930008994083","relation":{},"ISSN":["0891-6934","1607-842X"],"issn-type":[{"value":"0891-6934","type":"print"},{"value":"1607-842X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,1]]}}}